A PHASE 3 STUDY OF TENOFOVIR ALAFENAMIDE COMPARED WITH TENOFOVIR DISOPROXIL FUMARATE IN PATIENTS WITH HBEAG-NEGATIVE, CHRONIC HEPATITIS B: WEEK 48 EFFICACY AND SAFETY RESULTS

被引：6

作者：

Buti, M. ^{[1
]}

Gane, E. ^{[2
]}

Seto, W. K. ^{[3
]}

Chan, H. L. Y. ^{[4
]}

Chuang, W. -L. ^{[5
]}

Stepanova, T. ^{[6
]}

Hui, A. J. ^{[7
]}

Lim, Y. -S. ^{[8
]}

Mehta, R. ^{[9
]}

Janssen, H. L. A. ^{[10
,11
]}

Acharya, S. K. ^{[12
]}

Flaherty, J. F. ^{[13
]}

Massetto, B. ^{[13
]}

Cathcart, A. ^{[13
]}

Dinh, P. ^{[13
]}

Subramanian, G. M. ^{[13
]}

McHutchison, J. G. ^{[13
]}

Pan, C. ^{[14
]}

Brunetto, M. ^{[15
]}

Izumi, N. ^{[16
]}

Marcellin, P. ^{[17
]}

机构：

[1] Hosp Gen Univ Vall dHebron, Barcelona, Spain

[2] Auckland Clin Studies, Auckland, New Zealand

[3] Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China

[4] Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China

[5] Kaoshing Med Univ Hosp, Kaoshing, Taiwan

[6] Modern Med Clin, Moscow, Russia

[7] Alice Ho Miu Ling Nethersole Hosp, Hong Kong, Hong Kong, Peoples R China

[8] Asan Med Ctr, Seoul, South Korea

[9] Nirmal Hosp Private Ltd, Surat, India

[10] Toronto Western Hosp, Toronto, ON, Canada

[11] Erasmus MC, Rotterdam, Netherlands

[12] All India Inst Med Sci, New Delhi, India

[13] Gilead Sci, Foster City, CA USA

[14] New Discovery LLC, Flushing, NY USA

[15] Univ Hosp Pisa, Pisa, Italy

[16] Musashino Red Cross Hosp, Tokyo, Japan

[17] Hop Beaujon, Clichy, France

来源：

JOURNAL OF HEPATOLOGY | 2016年 / 64卷

关键词：

D O I：

10.1016/S0168-8278(16)01637-8

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

GS06

引用

页码：S135 / S136

页数：2

共 50 条

[31] Tenofovir alafenamide and tenofovir disoproxil fumarate reduce incidence of hepatocellular carcinoma in patients with chronic hepatitis B [J].

Lim, Young-Suk ;

Chan, Henry L. Y. ;

Ahn, Sang Hoon ;

Seto, Wai Kay ;

Ning, Qin ;

Agarwal, Kosh ;

Janssen, Harry L. A. ;

Pan, Calvin Q. ;

Chuang, Wan Long ;

Izumi, Namiki ;

Fung, Scott ;

Shalimar, Maurizia ;

Brunetto, Maurizia ;

Hui, Aric Josun ;

Chang, Ting-Tsung ;

Lim, Seng Gee ;

Abramov, Frida ;

Flaherty, John F. ;

Wang, Hongyuan ;

Yee, Leland J. ;

Kao, Jia-Horng ;

Gane, Edward ;

Hou, Jinlin ;

Buti, Maria .

JHEP REPORTS, 2023, 5 (10)

[32] FOUR YEARS EFFICACY AND SAFETY OF TENOFOVIR DISOPROXIL FUMARATE (TDF) IN ASIANS WITH HBEAG-POSITIVE AND HBEAG-NEGATIVE CHRONIC HEPATITIS B (CHB), PRELIMINARY ANALYSIS [J].

Gane, Edward J. ;

Lee, Samuel S. ;

Heathcote, E. Jenny ;

Sievert, William ;

Trinh, Huy N. ;

Kaita, Kelly D. ;

Younossi, Zobair M. ;

George, Jacob ;

Marcellin, Patrick ;

Coombs, Derek H. ;

Anderson, Jane ;

Mondou, Elsa .

HEPATOLOGY, 2010, 52 (04) :559A-559A

[33] Efficacy and safety of switching therapy from tenofovir disoproxil fumarate to tenofovir alafenamide for hepatitis B virus infection [J].

Kaneko, Shun ;

Kurosaki, Masayuki ;

Tamaki, Nobuharu ;

Itakura, Jun ;

Kirino, Sakura ;

Watakabe, Keiya ;

Osawa, Leona ;

Okada, Mao ;

Wan, Wang ;

Shimizu, Takao ;

Higuchi, Mayu ;

Takaura, Kenta ;

Yasui, Yutaka ;

Tsuchiya, Kaoru ;

Nakanishi, Hiroyuki ;

Takahashi, Yuka ;

Izumi, Namiki .

JOURNAL OF HEPATOLOGY, 2019, 70 (01) :E469-E469

[34] Two Type of Tenofovir Disoproxil Fumarate in Chinese Patients with Chronic Hepatitis B: FirstStage Results at Week 48 [J].

Liang Rongyue ;

Xu, Jinghang ;

Si, Chongwen ;

Wang, Sa ;

Shang, Jia ;

Yu, Zujiang ;

Mao, Qing ;

Xie, Qing ;

Zhao, Wei ;

Li, Jun ;

Gao, Zhiliang ;

Wu, Shanming ;

Tang, Hong ;

Cheng, Jun ;

Chen, Xinyue ;

Zhang, Wenhong ;

Wang, Hao ;

Xu, Zhongnan ;

Wang, Ling ;

Dai, Jun ;

Yu, Yanyan .

HEPATOLOGY, 2018, 68 :268A-268A

[35] EFFECTS OF TENOFOVIR ALAFENAMIDE FUMARATE VERSUS TENOFOVIR DISOPROXIL FUMARATE ON SERUM LIPID PROFILES IN PATIENTS WITH CHRONIC HEPATITIS B [J].

Cao, Fei ;

Fan, Tao ;

Jiang, Xue ;

Wang, Jian ;

Xiong, Ye ;

Zhang, Shaoqiu ;

Zhang, Zhiyi ;

Liu, Xingxiang ;

Zhu, Chuanwu ;

Li, Jie ;

Huang, Rui ;

Wu, Chao .

HEPATOLOGY, 2024, 80 :S298-S298

[36] CONTINUED EFFICACY AND SAFETY THROUGH 4 YEARS OF TENOFOVIR DISOPROXIL FUMARATE (TDF) TREATMENT IN HBEAG-NEGATIVE PATIENTS WITH CHRONIC HEPATITIS B (STUDY 102): PRELIMINARY ANALYSIS [J].

Marcellin, Patrick ;

Buti, Maria ;

Krastev, Zahary ;

Gurel, Selim ;

Di Bisceglie, Adrian M. ;

Odin, Joseph A. ;

Dusheiko, Geoffrey M. ;

Heathcote, E. Jenny ;

Borroto-Esoda, Katyna ;

Coombs, Derek H. ;

Mondou, Elsa ;

Anderson, Jane .

HEPATOLOGY, 2010, 52 (04) :555A-556A

[37] Two year safety and tolerability of tenofovir disoproxil fumarate treatment in HBeAg negative and HBeAg positive patients with chronic hepatitis B [J].

Gane, E. J. ;

Sievert, W. ;

Weilert, F. ;

George, J. ;

Strasser, S. I. ;

Crawford, D. ;

Moyes, C. ;

Heathcote, E. J. ;

Marcellin, P. ;

Sorbel, J. ;

Rousseau, F. .

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 :A309-A309

[38] THREE YEARS OF TENOFOVIR DISOPROXIL FUMARATE (TDF) TREATMENT IN HBEAG-NEGATIVE PATIENTS WITH CHRONIC HEPATITIS B (STUDY 102); PRELIMINARY ANALYSIS [J].

Marcellin, Patrick ;

Buti, Maria ;

Krastev, Zahary ;

Germanidis, George ;

Kaita, Kelly D. ;

Kotzev, Iskren ;

Buggisch, Peter ;

Weilert, Frank ;

Trinh, Huy N. ;

Gurel, Selim ;

Heathcote, E. Jenny ;

Sorbel, Jeff ;

Anderson, Jane ;

Mondou, Elsa ;

Rousseau, Franck .

HEPATOLOGY, 2009, 50 (04) :532A-533A

[39] Therapeutic effectiveness analysis of tenofovir alafenamide and tenofovir disoproxil fumarate on the treatment for chronic hepatitis B [J].

Liu, Rui ;

Qiao, Jin ;

Zhang, Lin ;

Dou, Zhihua .

MEDICINE, 2024, 103 (20) :E37953

[40] REAL WORLD COMPARISON OF RENAL SAFETY IN PATIENTS TREATED WITH TENOFOVIR DISOPROXIL FUMARATE VS TENOFOVIR ALAFENAMIDE FOR CHRONIC HEPATITIS B [J].

Zhang, Xueyun ;

Hu, Qiankun ;

Liu, Xiaoqin ;

Huang, Yuxian .

HEPATOLOGY, 2021, 74 :490A-491A

← 1 2 3 4 5 →